Syros Pharmaceuticals (SYRS) Financial Statements

Syros Pharmaceuticals's market cap is currently $5.37K. The company's EPS TTM is $; its P/E ratio is >-0.01; Syros Pharmaceuticals is scheduled to report earnings on July 31, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.